0001104659-20-009274.txt : 20200131
0001104659-20-009274.hdr.sgml : 20200131
20200131161558
ACCESSION NUMBER: 0001104659-20-009274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200131
FILED AS OF DATE: 20200131
DATE AS OF CHANGE: 20200131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McMillan Ellida
CENTRAL INDEX KEY: 0001604617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 814-01064
FILM NUMBER: 20565274
MAIL ADDRESS:
STREET 1: C/O ALCENTRA CAPITAL CORP., 200 PARK AVE
STREET 2: 7TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10166
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alcentra Capital Corp
CENTRAL INDEX KEY: 0001578620
IRS NUMBER: 000000000
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PARK AVENUE
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10166
BUSINESS PHONE: 212-922-8240
MAIL ADDRESS:
STREET 1: 200 PARK AVENUE
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10166
FORMER COMPANY:
FORMER CONFORMED NAME: Alcentra Capital Corp.
DATE OF NAME CHANGE: 20130605
4
1
tm206267d3_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-01-31
1
0001578620
Alcentra Capital Corp
ABDC
0001604617
McMillan Ellida
C/O ALCENTRA CAPITAL CORPORATION
200 PARK AVENUE, 7TH FLOOR
NEW YORK
NY
10166
0
1
0
0
CFO, COO, Treas. & Secretary
Common Stock
2020-01-31
4
D
0
2600
D
0
D
On January 31, 2020, pursuant to an Agreement and Plan of Merger dated as of August 12, 2019 (as amended on September 27, 2019, the "Merger Agreement"), Alcentra Capital Corporation ("Alcentra Capital") and Crescent Capital BDC, Inc. ("Crescent Capital BDC") effected a merger pursuant to which Crescent Capital BDC (following its reincorporation by merger into the State of Maryland) acquired all of the outstanding shares of Alcentra Capital's common stock in a multi-step stock and cash transaction (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, each issued and outstanding share of Alcentra Capital common stock was converted into the right to receive (1) 0.4041 shares of Crescent Capital BDC common stock and (2) $2.3784 in cash.
/s/ Steven Levinson, attorney-in-fact
2020-01-31